COA on Every ProductUSP Certified MaterialsProudly Canadian ManufacturerAll Excipients: USP-Grade ◆ Low Endotoxin ◆ Low MetalRaw Materials Sourced from GMP-Manufacturing FacilitiesCOA on Every ProductUSP Certified MaterialsProudly Canadian ManufacturerAll Excipients: USP-Grade ◆ Low Endotoxin ◆ Low MetalRaw Materials Sourced from GMP-Manufacturing Facilities
GLP3RT
GLP3RT - Image 2
GLP3RT - Image 3
GLP3RT - Image 4

GLP3RT

A research triple-receptor incretin peptide (GLP-1 / GIP / glucagon) for metabolic studies, available in multiple strengths. For research purposes only.

🇨🇦 Canadian First Lyfe is the first manufacturer of dual chamber pens in Canada. Learn More → View Certificate of Analysis Independent third‑party lab report · PDF

Description

GLP3RT is a research incretin-mimetic peptide with activity across three pathways – GLP-1, GIP and glucagon receptors – representing the triple-agonist class studied in metabolic research.

Commonly explored in research for:

  • Metabolic regulation and glucose-handling models
  • Energy expenditure and lipid-metabolism research
  • Body-weight and adiposity models
  • Multi-receptor incretin and glucagon signalling

Available in multiple strengths as lyophilized powder; also available in the Lyfe pen.

⚖️

Chemical Overview

Key identifiers & structural data

🔬 Structural Data

About GLP3RT

ClassificationGLP-3 receptor agonist
CAS RegistryProprietary
Molecular Mass~2400 g/mol
Residue Count20
Chain SequenceProprietary
Molecular FormulaProprietary
📑

Research Literature

Published studies & clinical data

Nature Medicine

GLP-1 receptor agonists in metabolic research

2021 • PMID: 33589815

Muller TD et al.

Read Paper ↗
Diabetes Care

Incretin-based therapies: mechanisms and applications

2020 • PMID: 31959645

Nauck MA, Meier JJ

Read Paper ↗
Cell Metabolism

GLP-1 and energy balance in preclinical models

2019 • PMID: 30982732

Drucker DJ

Read Paper ↗

Related products